NO20071208L - Trisykliske 5-opioidmodulatorer - Google Patents

Trisykliske 5-opioidmodulatorer

Info

Publication number
NO20071208L
NO20071208L NO20071208A NO20071208A NO20071208L NO 20071208 L NO20071208 L NO 20071208L NO 20071208 A NO20071208 A NO 20071208A NO 20071208 A NO20071208 A NO 20071208A NO 20071208 L NO20071208 L NO 20071208L
Authority
NO
Norway
Prior art keywords
tricyclic
modulators
opioid
opioid modulators
pharmaceutical
Prior art date
Application number
NO20071208A
Other languages
English (en)
Norwegian (no)
Inventor
Li Liu
Scott L Dax
Bart Decorte
Mark Mcdonnell
James J Mcnally
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20071208L publication Critical patent/NO20071208L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20071208A 2004-08-05 2007-03-05 Trisykliske 5-opioidmodulatorer NO20071208L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59913104P 2004-08-05 2004-08-05
PCT/US2005/027568 WO2007030089A1 (en) 2004-08-05 2005-08-02 Tricyclic delta- opioid modulators

Publications (1)

Publication Number Publication Date
NO20071208L true NO20071208L (no) 2007-04-19

Family

ID=37075386

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071208A NO20071208L (no) 2004-08-05 2007-03-05 Trisykliske 5-opioidmodulatorer

Country Status (17)

Country Link
US (2) US7553850B2 (es)
EP (1) EP1910353A1 (es)
JP (1) JP2008529971A (es)
KR (1) KR20080027216A (es)
CN (1) CN101039940A (es)
AR (1) AR050198A1 (es)
AU (1) AU2005335481A1 (es)
BR (1) BRPI0513075A (es)
CA (1) CA2574768A1 (es)
EA (1) EA200700403A1 (es)
EC (1) ECSP077230A (es)
IL (1) IL181120A0 (es)
NI (1) NI200700030A (es)
NO (1) NO20071208L (es)
TW (1) TW200621767A (es)
WO (1) WO2007030089A1 (es)
ZA (1) ZA200701875B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ572901A (en) 2003-06-27 2010-06-25 Janssen Pharmaceutica Nv Tricyclic delta opioid modulators
US7553850B2 (en) * 2004-08-05 2009-06-30 Janssen Pharmaceutica Nv Tricyclic-bridged piperidinylidene derivatives as δ-opioid modulators
WO2006069277A1 (en) * 2004-12-22 2006-06-29 Janssen Pharmaceutica N.V. TRICYCLIC δ-OPIOID MODULATORS
CA2592462A1 (en) * 2004-12-22 2006-06-29 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
EP1833826B1 (en) 2004-12-22 2009-05-27 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
KR20070104380A (ko) * 2005-01-06 2007-10-25 얀센 파마슈티카 엔.브이. 트리사이클릭 δ-오피오이드 조절제
RU2008101667A (ru) * 2005-06-16 2009-07-27 Янссен Фармацевтика Н.В. (Be) Трициклические модуляторы опиоидов
ES2422579T3 (es) * 2005-07-21 2013-09-12 Rensselaer Polytech Inst 2,6-Metano-3-benzazocinas 8-carboxamido sustituidas y 3-carboxamido morfanos sustituidos como ligandos de los receptores opioides
RS56181B1 (sr) 2011-06-29 2017-11-30 Alkermes Inc Periferno delujuća opioidna jedinjenja
WO2018083635A2 (en) 2016-11-04 2018-05-11 Auckland Uniservices Limited Tricyclic heterocyclic derivatives and uses thereof
KR102912926B1 (ko) 2018-07-19 2026-01-14 린트필드 리미티드 티오크산톤 유도체 및 이를 포함하는 조성물 및 상기 조성물을 포함하는 패턴 형성 방법｛Thioxanthone derivatives, composition comprising the same and pattern forming method comprising said composition｝

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2368006A (en) * 1943-10-07 1945-01-23 Searle & Co Heterocyclic tertiary amines
US2784185A (en) * 1953-03-27 1957-03-05 Promonta Chem Fab Phenothiazine compounds
US2901478A (en) * 1957-02-11 1959-08-25 Promonta Chem Fab Phenothiazine compounds
US3179665A (en) * 1959-12-16 1965-04-20 Wander Ag Dr A 9-(n-ethyl and n-propyl piperidyl-3'-methyl)-thioxanthenes
DE1159954B (de) * 1961-11-25 1963-12-27 Boehringer & Soehne Gmbh Verfahren zur Herstellung neuer 10-(Alkoxypiperidinopropyl)-phenthiazine und ihrer Salze
DE1670118A1 (de) 1966-07-22 1970-11-05 Boehringer Mannheim Gmbh Verfahren zur Herstellung neuer Derivate des 6,11-Dihydro-dibenz[b,e]oxepins und ihrer Salze
US3470188A (en) * 1967-01-05 1969-09-30 Smithkline Corp 9-cycloalkyl-lower alkyl-piperidylidene derivatives of xanthenes and thioxanthenes
NL6818027A (es) * 1968-01-09 1969-07-11
US3987042A (en) * 1969-03-03 1976-10-19 Claude Gueremy Phenothiazine derivative
GB1250534A (es) 1969-03-03 1971-10-20
US3931232A (en) * 1974-06-24 1976-01-06 Smithkline Corporation 3-Alkyl xanthene compounds
US4086350A (en) * 1974-11-06 1978-04-25 Smithkline Corporation Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms
ZA756550B (en) 1974-11-06 1976-09-29 Smithkline Corp Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms
US4285956A (en) 1978-05-12 1981-08-25 Kefalas A/S Xanthene and thioxanthene derivatives, compositions thereof and treatment therewith
US4356184A (en) * 1980-06-04 1982-10-26 G. D. Searle & Co. Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines
US4666907A (en) * 1983-10-05 1987-05-19 Merck Frosst Canada, Inc. Phenothiazine and derivatives and analogs and use as leukotriene biosynthesis inhibitors
US4777177A (en) * 1984-10-19 1988-10-11 Ciba-Geigy Corporation Pesticidal thioxanthen-9-ylidenepiperidines
FR2689013B1 (fr) * 1992-03-30 1995-05-05 Rhone Poulenc Rorer Sa Nouvelle application thérapeutique des dérivés de la phénothiazine.
ZA978792B (en) * 1996-10-04 1998-04-06 Novo Nordisk As N-substituted azaheterocyclic compounds.
SE9604786D0 (sv) * 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
TW548271B (en) 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
AU7907298A (en) 1997-06-25 1999-01-19 Novo Nordisk A/S Novel heterocyclic compounds
US6040318A (en) * 1997-06-25 2000-03-21 Novo Nordisk A/S Tricycle substituted with azaheterocyclic carboxylic acids
DK1049676T3 (da) 1997-12-24 2006-01-16 Ortho Mcneil Pharm Inc 4-[Aryl(piperidin-4-yl)]aminobenzamider, som binder til delta-opioidreceptoren
US7307990B2 (en) * 1999-01-19 2007-12-11 Cisco Technology, Inc. Shared communications network employing virtual-private-network identifiers
AU2063601A (en) 1999-12-22 2001-07-03 Ortho-Mcneil Pharmaceutical, Inc. 4-(aryl(8-azabicyclo(3.2.1)octan-3-yl))aminobenzoic acid derivatives
US6552036B2 (en) 2000-03-03 2003-04-22 Ortho-Mcneil Pharmaceutical, Inc. 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
US20030181447A1 (en) * 2001-02-22 2003-09-25 Boyd Robert E. 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
WO2001072303A1 (en) 2000-03-29 2001-10-04 Research Triangle Institute Selective ligands for the delta opioid receptor
EP1359146B1 (en) 2000-10-31 2008-04-09 Rensselaer Polytechnic Institute 4-aryl piperidines as opioid receptor binding agents
US6887876B2 (en) 2000-12-14 2005-05-03 Ortho-Mcneil Pharmaceutical, Inc. Benzamidine derivatives
US6601009B2 (en) * 2001-07-12 2003-07-29 Yahoo Inc Method and system of automatic bandwidth detection
US7060711B2 (en) * 2001-10-25 2006-06-13 Biofrontera Bioscience Gmbh Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
EP1306376A1 (en) 2001-10-25 2003-05-02 Biofrontera Pharmaceuticals AG Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
EP1321169A1 (en) 2001-12-18 2003-06-25 Biofrontera Pharmaceuticals AG Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament
US20060111342A1 (en) 2002-09-18 2006-05-25 Argentine Joseph A Insecticidal tricyclic derivatives
AU2003301299A1 (en) 2002-10-15 2004-05-04 Janssen Pharmaceutica, N.V. Benzyl substituted (piperidin-4-yl) aminobenzamido derivatives as delta-opiod receptor modulators
WO2004092165A1 (en) 2003-04-15 2004-10-28 Pfizer Products Inc. 3-benzhydrylidene-8-aza-bicyclo[3.2.1]octane derivatives with opioid receptor activity
NZ572901A (en) * 2003-06-27 2010-06-25 Janssen Pharmaceutica Nv Tricyclic delta opioid modulators
US7553850B2 (en) 2004-08-05 2009-06-30 Janssen Pharmaceutica Nv Tricyclic-bridged piperidinylidene derivatives as δ-opioid modulators
WO2006069277A1 (en) * 2004-12-22 2006-06-29 Janssen Pharmaceutica N.V. TRICYCLIC δ-OPIOID MODULATORS
EP1833826B1 (en) * 2004-12-22 2009-05-27 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
CA2592462A1 (en) * 2004-12-22 2006-06-29 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
KR20070104380A (ko) * 2005-01-06 2007-10-25 얀센 파마슈티카 엔.브이. 트리사이클릭 δ-오피오이드 조절제
RU2008101667A (ru) * 2005-06-16 2009-07-27 Янссен Фармацевтика Н.В. (Be) Трициклические модуляторы опиоидов

Also Published As

Publication number Publication date
AR050198A1 (es) 2006-10-04
US20060030585A1 (en) 2006-02-09
EA200700403A1 (ru) 2007-08-31
ZA200701875B (en) 2008-07-30
CA2574768A1 (en) 2006-02-05
AU2005335481A8 (en) 2008-12-11
KR20080027216A (ko) 2008-03-26
TW200621767A (en) 2006-07-01
IL181120A0 (en) 2008-03-20
WO2007030089A8 (en) 2007-05-31
JP2008529971A (ja) 2008-08-07
CN101039940A (zh) 2007-09-19
US20090291979A1 (en) 2009-11-26
WO2007030089A1 (en) 2007-03-15
EP1910353A1 (en) 2008-04-16
NI200700030A (es) 2008-02-04
AU2005335481A1 (en) 2007-04-19
ECSP077230A (es) 2007-04-26
US7553850B2 (en) 2009-06-30
BRPI0513075A (pt) 2008-04-22

Similar Documents

Publication Publication Date Title
NO20073776L (no) Trisykliske delta-opioidmodulatorer
NO20060446L (no) Trisykliske delta-opioidmodulatorer
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
MY142589A (en) Benzimidazole derivatives : preparation and pharmaceutical applications
NO20045043L (no) Pyrimidinonforbindelser, sammensetninger og fremgangsmater
MY151032A (en) Treatment of tnf? related disorders
NO20072352L (no) Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet
DK1305286T3 (da) Cyclopentanoindoler, præparater indeholdende sådanne forbindelser og fremgangsmåder til behandling
TW200716546A (en) Oxindole compounds and their uses as therapeutic agents
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
DK1654253T3 (da) Substituerede 3-pyrrolidinindolderivater
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
NO20060871L (no) Azepinderivater som farmasoytiske midler
WO2006047032A3 (en) Indole compounds useful as serotonin selective agents
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
NO20051304L (no) Agonisme av 5HT2a reseptoren for behandling av termoregulatorisk dysfunksjon
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
NO20053042L (no) Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
NI200700030A (es) Moduladores tricíclicos del delta-opioide
TW200716134A (en) Tricyclic opioid modulators
DE602005014566D1 (de) Chinolinon-carboxamid-verbindungen
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
EA200602115A1 (ru) Опиоидные соединения, замещенные карбоксамидогруппой
NO20065297L (no) Anvendelse av GPCR54 ligander til behandling av infertilitet
WO2006074388A3 (en) TRICYCLIC δ-OPIOID MODULATORS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application